|[June 30, 2014]
Research and Markets: Rosacea Pipeline Highlights - 2014 Update
DUBLIN --(Business Wire)--
Research and Markets (http://www.researchandmarkets.com/research/2qlb7c/rosacea_pipeline)
has announced the addition of the "Rosacea
Pipeline Highlights - 2014 Update" report to their offering.
The latest report Rosacea Pipeline Highlights - 2014 Update, provides
most up-to-date information on key pipeline molecules in the global
Rosacea market. It covers emerging therapies for Rosacea in active
clinical development stages including early and late stage clinical
trials. The pipeline data presented in this report helps executives for
tracking competition, identifying partners, evaluating opportunities,
formulating business developent strategies, and executing in-licensing
and out-licensing deals.
Clinical Trial Stages:
The report provides Rosacea pipeline molecules by clinical trial stages
including both early and late stage development - phase 3 clinical
trials, phase 2 clinical trials, phase 1 clinical trials, preclinical
research, and discovery stage.
Drug Mechanism Classes:
The report provides Rosacea pipeline molecules by their dominant
mechanism of action. This helps executives categorize molecules based on
their drug class and also assess the strengths and weaknesses of
The report provides Rosacea pipeline molecules by the Originator Company.
Short-term Launch Highlights:
Find out which Rosacea pipeline products will be launched in the US and
Ex-US till 2017.
Key Topics Covered:
1. Rosacea Pipeline by Stages
2. Rosacea Pipeline by Drug Class
3. Rosacea Pipeline by Company
4. Rosacea Phase 3 Clinical Trial Insights
5. Rosacea Phase 2 Clinical Trial Insights
6. Rosacea Phase 1 Clinical Trial Insights
7. Rosacea Preclinical Research Insights
8. Rosacea Discovery Stage Insights
10. Research Methodology
For more information visit http://www.researchandmarkets.com/research/2qlb7c/rosacea_pipeline
[ Back To Cloud Contact Center's Homepage ]